By Taylor Mixides (Drug Target Review)2023-08-21T12:52:52
Human papillomavirus (HPV)-associated head and neck cancers, specifically head and neck squamous cell carcinoma (HNSCC), are on the rise worldwide. Yet, the factors contributing to these tumours and their varying responses to treatment remain poorly understood.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-26T13:58:00Z
2026-03-25T15:00:00Z 2026-03-25T16:00:00Z
Sponsored by Yokogawa
2026-03-18T14:47:08Z
2024-03-08T10:00:25
Sponsored by Molecular Devices
2023-03-20T13:41:33
Sponsored by Bio-Techne
2024-01-26T13:22:42
Sponsored by bit.bio
2024-02-08T11:07:39
Sponsored by Samplix ApS
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2023-01-06T10:25:33
Sponsored by Leica Microsystems
Site powered by Webvision Cloud